According to a new market intelligence report by BIS Research titled ‘ Global DNA Damage Response Drugs Market − Analysis and Forecast, 2020-2030 ’ , the global DNA damage response drugs market was estimated to be $3.59 Billion in 2020 and is expected to reach $24.84 Billion by the end of 2030, growing at a CAGR of 21.33%during the forecast period. BIS Research Report: https://bisresearch.com/industry-report/dna-damage-response-drugs-market.html The North America region is expected to dominate the global DNA damage response drugs market during the forecast period, 2020-2030. The growing need to develop novel treatment options for cancer, increasing pharmaceutical R&D expenditure, rising research in the field of oncology, and growing prevalence of cancer are some of the underlying factors responsible for the growth of the North America DNA damage response drugs market. Also, the presence of major market players has contributed significantly to the large share of t...